Prophylactic Intrathecal Normal Saline for Prevention of Post Dural Puncture Headache in Women Undergoing Cesarean Section Under Spinal Anesthesia
NCT ID: NCT04393766
Last Updated: 2022-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
152 participants
INTERVENTIONAL
2020-02-23
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Contribution of Ondansetron to Preventing Post-Dural Puncture Headaches Following Spinal Anesthesia
NCT06444737
Pregabalin Versus Hydrocortisone for Postdural Puncture Headache After Spinal for Cesarean
NCT03910088
Effect of Intrathecal Neostigmine on Post-dural Puncture Headache.
NCT05289323
Norepinephrine Addition in Spinal Anesthesia of Caesarean Section
NCT03626454
Norepinephrine to Prevent Hypotension in Ceasrean Delivery
NCT05248932
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After Obtaining Ethical clearance from IRB, a Randomized Controlled Trial study will be conducted in Dilla University Referral Hospital from October 2019 to May, 2020. 152 mothers scheduled caesarean section under spinal anesthesia fulfilling the inclusion criteria will be allocated into two groups randomly with random sequence generated list obtained from R package (Random Allocation Rule function) software version 3.6. Data will be entered, cleaned by Epi-info version 7 and imported to Statistical Package for Social Sciences version 22 for analysis. Descriptive statistics will be run to see the overall distribution of the study subjects with regard to the variables under study. Unpaired student's T-test for continuous symmetric data and Mann Whitney U test for non-normally distributed data will be used to see the mean difference between the groups. Categorical data will be analyzed with Chi square and fisher's exact test where appropriate. Survival analysis will be done to estimate the probability having PDPH within five days postoperatively.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
normal saline
Normal Saline
normal saline(crystalloids)
non normal saline
Normal Saline
normal saline(crystalloids)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Normal Saline
normal saline(crystalloids)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Term pregnant lady
Exclusion Criteria
* previous history of PDPH
* previous history of migraine headache
* BMI greater than 25 kg/m2
18 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dilla University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Semagn Mekonnen
Assistant professor of Anesthesiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yassin
Addis Ababa, Dilla, Ethiopia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0014/19-11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.